Unknown

Dataset Information

0

Dysbindin-1 Involvement in the Etiology of Schizophrenia.


ABSTRACT: Schizophrenia is a major psychiatric disorder that afflicts about 1% of the world's population, falling into the top 10 medical disorders causing disability. Existing therapeutic strategies have had limited success on cognitive impairment and long-term disability and are burdened by side effects. Although new antipsychotic medications have been launched in the past decades, there has been a general lack of significant innovation. This lack of significant progress in the pharmacotherapy of schizophrenia is a reflection of the complexity and heterogeneity of the disease. To date, many susceptibility genes have been identified to be associated with schizophrenia. DTNBP1 gene, which encodes dysbindin-1, has been linked to schizophrenia in multiple populations. Studies on genetic variations show that DTNBP1 modulate prefrontal brain functions and psychiatric phenotypes. Dysbindin-1 is enriched in the dorsolateral prefrontal cortex and hippocampus, while postmortem brain studies of individuals with schizophrenia show decreased levels of dysbindin-1 mRNA and protein in these brain regions. These studies proposed a strong connection between dysbindin-1 function and the pathogenesis of disease. Dysbindin-1 protein was localized at both pre- and post-synaptic sites, where it regulates neurotransmitter release and receptors signaling. Moreover, dysbindin-1 has also been found to be involved in neuronal development. Reduced expression levels of dysbindin-1 mRNA and protein appear to be common in dysfunctional brain areas of schizophrenic patients. The present review addresses our current knowledge of dysbindin-1 with emphasis on its potential role in the schizophrenia pathology. We propose that dysbindin-1 and its signaling pathways may constitute potential therapeutic targets in the therapy of schizophrenia.

SUBMITTER: Wang H 

PROVIDER: S-EPMC5666726 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dysbindin-1 Involvement in the Etiology of Schizophrenia.

Wang Haitao H   Xu Jiangping J   Lazarovici Philip P   Zheng Wenhua W  

International journal of molecular sciences 20170922 10


Schizophrenia is a major psychiatric disorder that afflicts about 1% of the world's population, falling into the top 10 medical disorders causing disability. Existing therapeutic strategies have had limited success on cognitive impairment and long-term disability and are burdened by side effects. Although new antipsychotic medications have been launched in the past decades, there has been a general lack of significant innovation. This lack of significant progress in the pharmacotherapy of schizo  ...[more]

Similar Datasets

| S-EPMC9258742 | biostudies-literature
| S-EPMC3063306 | biostudies-literature
| S-EPMC4188970 | biostudies-literature
| S-EPMC3055383 | biostudies-literature
| S-EPMC6230503 | biostudies-literature
| S-EPMC2246024 | biostudies-literature
| S-EPMC4358130 | biostudies-literature
| S-EPMC2748893 | biostudies-literature
| S-EPMC3321231 | biostudies-literature
| S-EPMC4572075 | biostudies-literature